0001780610-20-000001.txt : 20200430 0001780610-20-000001.hdr.sgml : 20200430 20200430145104 ACCESSION NUMBER: 0001780610-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200430 DATE AS OF CHANGE: 20200430 EFFECTIVENESS DATE: 20200430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OncoSenX, Inc. CENTRAL INDEX KEY: 0001780610 IRS NUMBER: 823491338 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-343617 FILM NUMBER: 20835077 BUSINESS ADDRESS: STREET 1: 800 5TH AVE STE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206-880-1166 MAIL ADDRESS: STREET 1: 800 5TH AVE STE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D/A 1 primary_doc.xml X0708 D/A LIVE 0001780610 OncoSenX, Inc. 800 5TH AVE STE 4100 SEATTLE WA WASHINGTON 98104 206-880-1166 DELAWARE Oisin Oncology, Inc. None Corporation true 2017 Matthew Scholz 800 5th Ave Ste 4100 Seattle WA WASHINGTON 98104 Executive Officer Director John Lewis 800 5th Ave Ste 4100 Seattle WA WASHINGTON 98104 Executive Officer Director Gary Hudson 800 5th Ave Ste 4100 Seattle WA WASHINGTON 98104 Director Other Decline to Disclose 06b true 0001780610-19-000001 2017-12-22 true true false 0 5500000 4136946 1363054 false 62 0 0 0 false OncoSenX, Inc. /s/ Matthew Scholz Matthew Scholz CEO 2020-04-30